Old Web
English
Sign In
Acemap
>
authorDetail
>
Ling Mo
Ling Mo
Bristol-Myers Squibb
General surgery
NS5A
Daclatasvir
Asunaprevir
Medicine
2
Papers
34
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Daclatasvir plus asunaprevir in treatment-naïve patients with hepatitis C virus genotype 1b infection
2018
World Journal of Gastroenterology
Lai Wei
Fu-Sheng Wang
Ming-Xiang Zhang
Ji Dong Jia
Alexey Yakovlev
Wen Xie
Eduard Burnevich
Jun-Qi Niu
Yong Jin Jung
Xiang-Jun Jiang
Min Xu
Xin Yue Chen
Qing Xie
Jun Li
Jin Lin Hou
Hong Tang
Xiao Guang Dou
Yash Gandhi
Wen Hua Hu
Fiona McPhee
Stephanie Noviello
Michelle Treitel
Ling Mo
Jun Deng
Show All
Source
Cite
Save
Citations (5)
A phase 3, open-label study of daclatasvir plus asunaprevir in Asian patients with chronic hepatitis C virus genotype 1b infection who are ineligible for or intolerant to interferon alfa therapies with or without ribavirin.
2016
Journal of Gastroenterology and Hepatology
Lai Wei
Mingxiang Zhang
Min Xu
Wan-Long Chuang
Wei Lu
Wen Xie
Zhansheng Jia
Guozhong Gong
Yueqi Li
Si Hyun Bae
Yongfeng Yang
Qing Xie
Shumei Lin
Xinyue Chen
Junqi Niu
Jidong Jia
Tushar Garimella
Anne Torbeyns
Fiona McPhee
Michelle Treitel
Philip D. Yin
Ling Mo
Show All
Source
Cite
Save
Citations (29)
1
map